Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IPAB Legislation Fast-Track Process Will Likely Need Clarification -- CRS

Executive Summary

The “enforceability and mechanics” of Congress’ fast-track consideration of Medicare cuts recommended by the Independent Payment Advisory Board will likely need to be clarified, according to the Congressional Research Service.

You may also be interested in...



Hearings Show IPAB Has Little Support In House, But Does It Matter?

Two congressional hearings during the week of July 15 confirmed there is little support in the House for the Independent Payment Advisory Board and its broad power to make cost-cutting changes to Medicare.

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says

The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel